Xenon Pharmaceuticals
XENE
#3698
Rank
โ‚ฌ2.95 B
Marketcap
38,25ย โ‚ฌ
Share price
-1.07%
Change (1 day)
-3.89%
Change (1 year)

Xenon Pharmaceuticals (XENE) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.52 Billion

According to Xenon Pharmaceuticals's latest financial reports the company's total assets are โ‚ฌ0.52 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Xenon Pharmaceuticals - Total assets on balance sheet (from 2013 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.76 B-12.12%
2023-12-31โ‚ฌ0.87 B24.14%
2022-12-31โ‚ฌ0.70 B39.2%
2021-12-31โ‚ฌ0.50 B228.38%
2020-12-31โ‚ฌ0.15 B16.66%
2019-12-31โ‚ฌ0.13 B23.2%
2018-12-31โ‚ฌ0.10 B178.41%
2017-12-31โ‚ฌ38.43 M-40.09%
2016-12-31โ‚ฌ64.16 M9.7%
2015-12-31โ‚ฌ58.48 M-18.63%
2014-12-31โ‚ฌ71.87 M82.18%
2013-12-31โ‚ฌ39.45 M-17.56%
2012-12-31โ‚ฌ47.85 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Coherus BioSciences
CHRS
โ‚ฌ0.44 B-15.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
โ‚ฌ31.69 M-93.93%๐Ÿ‡บ๐Ÿ‡ธ USA